Neurelis, Inc. is an innovation-driven neuroscience company focused on the development and commercialization of product candidates and innovative delivery technologies for the broader central nervous system (CNS), including epilepsy and psychiatry. In 2020, Neurelis reached a milestone in patient care with its first FDA-approved treatment. For information, please visit http://www.neurelis.com.
Neurelis Inc.
3430 Carmel Mountain Rd
Suite 300
San Diego, CA 92121
AAP Nat Con